SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy’s arm, Curis ink pact to develop select cancer therapies

23 Jan 2015 Evaluate

US-based biotechnology company Curis, Inc has entered into an exclusive collaboration pact with Aurigene Discovery Technologies, an independent wholly-owned subsidiary of Dr Reddy’s Laboratories for focusing on development of select cancer therapies.

The collaboration provides for inclusion of multiple programmes and Curis retains the option to license compounds once a development candidate is nominated within each respective programme. The collaboration focuses on immuno-oncology and selected precision oncology targets.

The partnership draws from each company’s respective areas of expertise, with Aurigene having the responsibility for conducting all discovery and pre-clinical activities while Curis is responsible for all clinical development, regulatory and commercialisation efforts worldwide, excluding India and Russia.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1306.80 -3.70 (-0.28%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×